CAIRO, March 30, 2026 /PRNewswire/ -- H.E. Sherif Fathy, Minister of Tourism and Antiquities, confirmed that the government's recently announced…
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in…
Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director Paris, March 5, 2026. The Board of Directors of Sanofi has…
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that…
Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Recommendation supported by safety and efficacy…
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on…
Press Release Evolution of PROACTIS SA Governance PARIS, France – (19 December 2025) — Under the terms of the Board…
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data…
Transparency Notification from Shareholder Ghent, Belgium – 13 October 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or…
SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- JNH PRESS, a leading Korean press manufacturer, celebrated a major milestone with…